1.
Arzneimittelforschung
; 36(2A): 394-7, 1986 Feb.
Article
in English
| MEDLINE
| ID: mdl-3707656
ABSTRACT
50 patients with congestive heart failure underwent monitored long-term treatment aimed at evaluating the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine, on their condition. Ibopamine was administered alone or in combination with traditional therapy mainly at a dose of 100 mg t.i.d. Clinical scores and NYHA (New York Heart Association) functional classes improved. Biochemical parameters showed no adverse modifications. Mild transient side-effects probably related to ibopamine occurred in two patients.
Subject(s)
Cardiotonic Agents/therapeutic use , Deoxyepinephrine/analogs & derivatives , Dopamine/analogs & derivatives , Heart Failure/drug therapy , Adult , Aged , Body Weight/drug effects , Cardiotonic Agents/adverse effects , Chronic Disease , Deoxyepinephrine/adverse effects , Deoxyepinephrine/therapeutic use , Female , Heart Failure/physiopathology , Heart Rate/drug effects , Hemodynamics/drug effects , Humans , Male , Middle Aged , Monitoring, Physiologic , Time Factors
2.
Boll Soc Ital Cardiol
; 25(6): 611-8, 1980.
Article
in Italian
| MEDLINE
| ID: mdl-7284166